Startups pioneering invasive and noninvasive devices that interact with the brain seek to alleviate everything from ALS symptoms to epilepsy to treatment-resistant depression. In this episode, a look at the science behind this rapidly advancing technology.
Dr. Thomas Oxley, a neurointerventionist and CEO of Synchron, gives us a tour of his lab in Brooklyn, New York, where his company is developing an implant that allows paralyzed people to control devices.
Then Bloomberg reporter Sarah McBride joins Wes for a look at other startups making these brain-computer interfaces–and where the industry goes from here.
Listen to The Big Take podcast every weekday and subscribe to our daily newsletter: https://bloom.bg/3F3EJAK
Have questions or comments for Wes and the team? Reach us at bigtake@bloomberg.net.
See omnystudio.com/listener for privacy information.
